STANDARD BIOTOOLS INC. - COMMON STOCK

Fluidigm Announces Preliminary Revenue Exceeding Guidance for the Fourth Quarter and Full Year 2021

11 Jan 2022 07:00:01 By Nasdaq GlobeNewswire

Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company’s Biomark Platform Detects Omicron Variant of COVID-19

07 Dec 2021 07:30:00 By Nasdaq GlobeNewswire

Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

16 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Biomark X Offers Industry-Leading Advantages in Speed, Throughput, Flexibility and Cost

11 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Fluidigm Announces Third Quarter 2021 Financial Results

08 Nov 2021 15:02:00 By Nasdaq GlobeNewswire

Imaging Mass Cytometry Utilized to Seek Molecular Links between African Ancestry and Aggressive Forms of Breast and Prostate Cancer

08 Nov 2021 07:30:01 By Nasdaq GlobeNewswire

Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results

20 Oct 2021 07:30:00 By Nasdaq GlobeNewswire

Fluidigm 2021 IMC Summit Focuses on ‘Uncovering Spatial Biology’

18 Oct 2021 07:30:00 By Nasdaq GlobeNewswire

Fluidigm Announces New Co-Marketing Program under Collaboration Agreement with Visiopharm, Offering AI-Based Image Analysis Software

12 Oct 2021 07:30:00 By Nasdaq GlobeNewswire

Fluidigm Announces Collaboration Agreement with Karolinska Institutet to Accelerate Customer Adoption of New CyTOF XT

28 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference

02 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

CyTOF and Maxpar Direct Technologies Utilized in Study Characterizing Immune and Inflammatory Responses in Pregnant Women Infected with SARS-CoV-2

31 Aug 2021 07:30:00 By Nasdaq GlobeNewswire

Fluidigm to Participate in UBS Genomics 2.0 and MedTech Innovations Summit

09 Aug 2021 10:14:28 By Nasdaq GlobeNewswire

Fluidigm Announces Second Quarter 2021 Financial Results with Total Revenue of $31.0 Million

05 Aug 2021 15:05:01 By Nasdaq GlobeNewswire

Fluidigm Announces Collaboration Agreement with Imaging CRO ImaBiotech to Increase Biopharma Access to Imaging Mass Cytometry

05 Aug 2021 07:35:00 By Nasdaq GlobeNewswire

Fluidigm Announces Co-Marketing Agreement with Ultivue for Biomarker Imaging Solutions for Precision Medicine

05 Aug 2021 07:30:01 By Nasdaq GlobeNewswire

Fluidigm Announces Conference Call and Webcast of Second Quarter 2021 Financial Results

08 Jul 2021 15:01:00 By Nasdaq GlobeNewswire

Next-Generation CyTOF XT Redefines Cytometry with Advances in Automation, Throughput, Time to Results and Total Cost of Ownership

25 May 2021 13:00:00 By Nasdaq GlobeNewswire

Imaging Mass Cytometry Utilized by Global Consortium Focused on New Precision Medicine Approaches for Treatment of Rheumatoid Arthritis

24 May 2021 07:30:00 By Nasdaq GlobeNewswire

Fluidigm to Present at Upcoming Investor Conferences

14 May 2021 07:30:01 By Nasdaq GlobeNewswire